Atorvia Health Technologies

Atorvia is focused on the prevention and treatment of organ failure, starting in the kidney.  Targeting a previously unknown functional role of a protein involved in the regulated cell death pathway, Atorvia’s lead program is a first-in-class small peptide therapeutic that prevents and treats kidney failure caused by ischemia.  Potential applications include the prevention of Acute Kidney Injury in patients undergoing surgery such as cardiac bypass or transplant procedures.